Richard Pollock
Senior Health Economist at Covalence Research Ltd- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
German Limited working proficiency
Topline Score
Bio
John Lyttle
Richard has proven to be an excellent leader of the team at Ossian both in terms of his pragmatic approach to getting the job done and ensuring his team made the required amendments requested often at the last minute. Despite being the second agency to work on the project with the challenge of redeveloping the compliance documentation. We are very confident that the patient access support materials we have developed together will facilitate successful negotiations with payers and policymakers.
John Lyttle
Richard has proven to be an excellent leader of the team at Ossian both in terms of his pragmatic approach to getting the job done and ensuring his team made the required amendments requested often at the last minute. Despite being the second agency to work on the project with the challenge of redeveloping the compliance documentation. We are very confident that the patient access support materials we have developed together will facilitate successful negotiations with payers and policymakers.
John Lyttle
Richard has proven to be an excellent leader of the team at Ossian both in terms of his pragmatic approach to getting the job done and ensuring his team made the required amendments requested often at the last minute. Despite being the second agency to work on the project with the challenge of redeveloping the compliance documentation. We are very confident that the patient access support materials we have developed together will facilitate successful negotiations with payers and policymakers.
John Lyttle
Richard has proven to be an excellent leader of the team at Ossian both in terms of his pragmatic approach to getting the job done and ensuring his team made the required amendments requested often at the last minute. Despite being the second agency to work on the project with the challenge of redeveloping the compliance documentation. We are very confident that the patient access support materials we have developed together will facilitate successful negotiations with payers and policymakers.
Experience
-
Covalence Research Ltd
-
United Kingdom
-
Hospitals and Health Care
-
1 - 100 Employee
-
Senior Health Economist
-
Dec 2018 - Present
-
-
-
Ossian Health Economics and Communications
-
Switzerland
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Health Economist
-
Feb 2009 - Nov 2018
Budget impact and cost-effectiveness/cost-utility analysis, global value dossier preparation, systematic literature review and manuscript/abstract/poster writing. Budget impact and cost-effectiveness/cost-utility analysis, global value dossier preparation, systematic literature review and manuscript/abstract/poster writing.
-
-
-
IMS Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Health Economics and Outcomes Research Analyst
-
Feb 2008 - Jan 2009
-
-
-
spirul
-
United Kingdom
-
Market Research
-
1 - 100 Employee
-
Market researcher and IT support
-
Dec 2007 - Jan 2008
-
-
-
MRC Laboratory of Molecular Biology (LMB)
-
United Kingdom
-
Research Services
-
200 - 300 Employee
-
Researcher
-
Oct 2006 - Nov 2007
Worked on increasing the temporal and spatial resolution of the transcription factor expression map in the tracheal system of Drosophila melanogaster. Developed (and published) BioSAVE software for quickly viewing scored DNA and protein sequence annotations. Worked on increasing the temporal and spatial resolution of the transcription factor expression map in the tracheal system of Drosophila melanogaster. Developed (and published) BioSAVE software for quickly viewing scored DNA and protein sequence annotations.
-
-
Education
-
2003 - 2007
University of Cambridge
MA MSci, Natural Sciences
